Honest uncertainty and incomplete disclosure are not the same thing. FDA's November 29, 2016 final import-data rule drew that distinction by allowing UNK for an article's intended-use code at entry while declining that placeholder for other required elements. The arrangement acknowledged a specific unknown without making the rest of the declaration optional. [2016-28582]
That boundary matters to both the person submitting a record and the people relying on FDA's admissibility review. The agency clarified in section 1.81 that it could reject a filing without complete and accurate required information. UNK did not assure release, and FDA said it would usually lead to manual review. A label that admits uncertainty cannot reasonably be presented as a promise of clearance. [2016-28582]
The July proposal adds a different fairness consideration: its electronic-data design expressly left paper entries and entry summaries available. That historical scope statement should not be inflated into a blanket final exemption. It does show why digital administration and truthful disclosure must be discussed separately. These are two stages of one agency process, not independent proof that filers received equal treatment. [2016-15684][2016-28582]
The final rule specified December 29 effectiveness and sought more efficient review of products presenting public-health risks. From an ethical perspective, clear declarations respect the limits of the regulator's knowledge as well as the interests of people using imported products. Whether the design improved those decisions remained unproven in the documents; the obligation to describe its limits accurately did not depend on that outcome. [2016-28582]
Source documents
- Submission of Food and Drug Administration Import Data in the Automated Commercial Environmenthttps://www.govinfo.gov/content/pkg/FR-2016-11-29/html/2016-28582.htm
- Submission of Food and Drug Administration Import Data in the Automated Commercial Environmenthttps://www.govinfo.gov/content/pkg/FR-2016-07-01/html/2016-15684.htm
